Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients

MLA

Xiao-Fei Zhang, et al. “Bcl-2 Expression Is a Poor Predictor for Hepatocellular Carcinoma Prognosis of Andropause-Age Patients.” Cancer Biology & Medicine, vol. 13, no. 4, Dec. 2016, pp. 459–68. EBSCOhost, https://doi.org/10.20892/j.issn.2095-3941.2016.0077.

APA

Xiao-Fei Zhang, Xin Yang, Hu-Liang Jia, Wen-Wei Zhu, Lu Lu, Wei Shi, Hao Zhang, Jin-Hong Chen, Yi-Feng Tao, Zheng-Xin Wang, Jun Yang, Lian-Xin Wang, Ming Lu, Yan Zheng, Jing Zhao, Qiong-Zhu Dong, & Lun-Xiu Qin. (2016). Bcl-2 expression is a poor predictor for hepatocellular carcinoma prognosis of andropause-age patients. Cancer Biology & Medicine, 13(4), 459–468. https://doi.org/10.20892/j.issn.2095-3941.2016.0077

Chicago

Xiao-Fei Zhang, Xin Yang, Hu-Liang Jia, Wen-Wei Zhu, Lu Lu, Wei Shi, Hao Zhang, et al. 2016. “Bcl-2 Expression Is a Poor Predictor for Hepatocellular Carcinoma Prognosis of Andropause-Age Patients.” Cancer Biology & Medicine 13 (4): 459–68. doi:10.20892/j.issn.2095-3941.2016.0077.